Exact Mass: 426.195
Exact Mass Matches: 426.195
Found 500 metabolites which its exact mass value is equals to given mass value 426.195
,
within given mass tolerance error 0.05 dalton. Try search metabolite list with more accurate mass tolerance error
0.01 dalton.
Paliperidone
Paliperidone is the primary active metabolite of the older antipsychotic risperidone. While its specific mechanism of action is unknown, it is believed that paliperidone and risperidone act via similar if not the same pathways. It has been proposed that the drugs therapeutic activity in schizophrenia is mediated through a combination of central dopamine Type 2 (D2) and serotonin Type 2 (5HT2A) receptor antagonism. Paliperidone is also active as an antagonist at alpha 1 and alpha 2 adrenergic receptors and H1 histaminergic receptors, which may explain some of the other effects of the drug. Paliperidone was approved by the FDA for treatment of schizophrenia on December 20, 2006. D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics Paliperidone (9-Hydroxyrisperidone), the major active metabolite of Risperidone, is a dopamine D2 antagonist and 5-HT2A antagonist. Paliperidone is also active as an antagonist at α1 and α2 adrenergic receptors and H1-histaminergic receptors. Paliperidone, a antipsychotic agent, shows efficacy against schizophrenia[1]. Paliperidone (9-Hydroxyrisperidone), the major active metabolite of Risperidone, is a dopamine D2 antagonist and 5-HT2A antagonist. Paliperidone is also active as an antagonist at α1 and α2 adrenergic receptors and H1-histaminergic receptors. Paliperidone, a antipsychotic agent, shows efficacy against schizophrenia[1].
Cariprazine
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics Cariprazine is a novel antipsychotic agent candidate that exhibits high affinity for the D3 (Ki=0.085 nM) and D2 (Ki=0.49 nM) receptors, and moderate affinity for the 5-HT1A receptor (Ki=2.6 nM).
1-[3-(3,7-dimethylocta-2,6-dien-1-yl)-2,4,5,6-tetrahydroxyphenyl]-3-(4-hydroxyphenyl)propan-1-one
(Z)-Narceine imide
(Z)-Narceine imide is an alkaloid from Papaver somniferum (opium poppy
11,13-Dihydrotaraxinic acid glucosyl ester
Constituent of Taraxacum officinale (dandelion). 11,13-Dihydrotaraxinic acid glucosyl ester is found in many foods, some of which are tea, alcoholic beverages, coffee and coffee products, and dandelion. 11,13-Dihydrotaraxinic acid glucosyl ester is found in alcoholic beverages. 11,13-Dihydrotaraxinic acid glucosyl ester is a constituent of Taraxacum officinale (dandelion)
(2,3-Dihydro-5-methyl-3-((4-morpholinyl)methyl)pyrrolo-(1,2,3-de)-1,4-benzoxazin-6-yl)(1-naphthalenyl)methanone monomethanesulfonate
9-Hydroxy-risperidone
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants
Gemfibrozil 1-O-beta-Glucuronide
Iloperidone
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics Iloperidone (HP 873) is a D2/5-HT2 receptor antagonist. Iloperidone is an atypical antipsychotic for the schizophrenia symptoms[1][2].
MEK inhibitor
Mespirenone
Ripisartan
Sonchuside E
Broussoflavan A
2,4,6,3,4-Pentahydroxy-3,5-diprenyldihydrochalcone
(5-methyl-3-(morpholinomethyl)-2,3-dihydro-[1,4]oxazino[2,3,4-hi]indol-6-yl)(naphthalen-1-yl)methanone
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002491 - Central Nervous System Agents > D000700 - Analgesics D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators
(+)-3,4-(6,6-dimethyldihydropyrano)-4,5-[2-(1-hydroxy-1-methylethyl)-dihydrofurano]-2,3-dihydroxydihydrochalcone|bartericin C
3-O-beta-D-glucopyranosyl-3beta,14-dihydroxycostunolide
1,8-dihydroxy-3-(3,7-dimethyl-7-methoxyoct-2-enyloxy)-6-methyl xanthone
7beta-O-beta-glucopyranosyl bombaxone|7beta-O-beta-glucopyranosyl-10beta-hydroxy hibiscone B
16,19-Secostrychnidine-10,16-dione, 21,22-epoxy-21,22-dihydro-14-hydroxy-4-methoxy-19-methyl-, (21.alpha.,22.alpha.)-
Hexyl 6-O-(beta-D-glucopyranosyl)-beta-D-glucopyranoside|Hexyl-??-D-glucopyranosyl-(1鈥樏傗垎 6)-??-D-glucopyranoside
1beta-O-((E)-p-methoxycinnamoyl)-6alpha-hydroxypolygodial|1beta-[(E-p-methoxycinnamoyl)oxy]-6alpha-hydroxypolygodial|isodrimanial
10beta,14-dihydroxy-10(14),11beta(13)-tetrahydro-8,9-didehydro-3-deoxyzaluzanin C-10-O-beta-glucopyranoside
1-[3-(6,7-dihydroxy-3,7-dimethyloct-2-enyl)-2,4-dihydroxyphenyl]-3-(4-hydroxyphenyl)prop-2-en-1-one
8beta-hydroxy-4alpha,15-dihydrozaluzanin C-3-O-beta-glucopyranoside
(1R,5R,6R,7S,9R)-6,9alpha-epoxy-9,15-bisabolanolide-5-O-beta-D-glucopyranoside|abiespiroside A
(3S)-3-hydroxyatractylenolide III 3-O-beta-D-glucopyranoside|(3S)-3-Hydroxyatractylenolide III 3-O-??-D-glucopyranoside|(3S,5R,8R,10R)-3,8-dihydroxyeudesma-4(15),7(11)-diene-8,12-olide 3-O-beta-D-glucopyranoside
cynarascoloside C|isoamberboin 8-O-beta-D-glucopyranoside
4alpha-O-beta-D-glucopyranosyl-15-hydroxyl-5alpha,6betaH-guaiane-10(14),11(13)-dien-12,6alpha-olide
(2R,3R)-7,4-dihydroxy-6-(3-hydroxy-3-methylbutyl)-8-(3-methylbut-2-en-1-yl)dihydroflavonol
13,17-epoxy-1beta,11beta,12alpha,14beta,15beta-pentahydroxy-2alpha-methoxypicras-3-en-16-one|bruceine M
Hexyl beta-sophoroside|Hexyl-??-D-glucopyranosyl-(1鈥樏傗垎 2)-??-D-glucopyranoside
11,13-dihydro-taraxinic acid 14-O-beta-D-glucoside|11,13-Dihydro-Taraxinsaeure-1-O-beta-D-Glucopyranosid|11,13-dihydrotaraxinic acid-beta-glucopyranosyl ester|11beta,13-dihydrotaraxinic acid beta-glucopyranosyl ester|11??,13-Dihydro-taraxinic acid-1-O-??-D-glucopyranoside
1(10)E-4Z-3alpha-hydroxy-germacra-1(10),4,11(13)-trien-6,12-olide-14-O-beta-D-glucopyranoside
(4-methylpentyl-beta-D-glucopyranosyl-(1->6)-beta-D-glucopyranoside|capsoside B
11beta,13-dihydrodesacylcynaropicrin 8-beta-D-glucoside|11beta,13-dihydrodesacylcynaropicrin-8-beta-D-glucoside|11betaH-11,13-dihydrodesacylcynaropicrin 8-beta-D-glucoside|3beta-hydroxy-11beta,13-dihydro-8alpha-O-beta-D-glucozaluzanin C
(2R,3R)-pterosin L 3-O-beta-D-glucopyranoside|2R,3R-pterosin L 3-O-beta-D-glucopyranoside
2,4,6,3,4-Pentahydroxy- 3,5-diprenyldihydrochalcone
2-Methylbutanoic acid 3-[2-(3,4-dimethoxyphenyl)-7-methoxybenzofuran-5-yl]propyl ester
fukanedone E|rel-3(S)-(2-hydroxy-4-methoxybenzoyl)-4(R),5(R)-dimethyl-5-[4-methyl-5-(4-methyl-2-furyl)-3(E)-penten-1-yl]tetrahydro-2-furanone
15-glucopyranosyloxy-2-oxo-guai-3-en-1alpha,5alpha,6beta,7a,10alpha,11betaH-12,6-olide
4alpha-hydroxy-5alpha,8betaH-lindan-7(11)-en-8alpha,12-olide-15-O-beta-D-glucopyranoside|sarcaglaboside G
alpha,3,4,2,4-Pentahydroxy-5,3-diprenyl-alpha,beta-dihydro-trans-chalcone
2-[6-hydroxy-3,7-dimethylocta-2(E),7-dienyl]-2,3,4,4-tetrahydroxydihydrochalcone
ABA-GE cpd
(+)-abscisic acid beta-D-glucopyranosyl ester is a (+)-abscisic acid D-glucopyranosyl ester that is derived from beta-D-glucopyranose. It is functionally related to a (+)-abscisic acid and a beta-D-glucose. (+)-abscisic acid beta-D-glucopyranosyl ester is a natural product found in Salacia chinensis, Arabidopsis thaliana, and other organisms with data available. D020011 - Protective Agents > D000975 - Antioxidants > D002338 - Carotenoids
Paliperidone
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C66883 - Dopamine Antagonist N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics CONFIDENCE standard compound; INTERNAL_ID 1568 Paliperidone (9-Hydroxyrisperidone), the major active metabolite of Risperidone, is a dopamine D2 antagonist and 5-HT2A antagonist. Paliperidone is also active as an antagonist at α1 and α2 adrenergic receptors and H1-histaminergic receptors. Paliperidone, a antipsychotic agent, shows efficacy against schizophrenia[1]. Paliperidone (9-Hydroxyrisperidone), the major active metabolite of Risperidone, is a dopamine D2 antagonist and 5-HT2A antagonist. Paliperidone is also active as an antagonist at α1 and α2 adrenergic receptors and H1-histaminergic receptors. Paliperidone, a antipsychotic agent, shows efficacy against schizophrenia[1].
8-(2,4-dihydroxy-6-pentylphenoxy)-6-hydroxy-3-pentylisochromen-1-one
[5-formyl-4,8-dihydroxy-3-(3-methoxy-3-oxoprop-1-en-2-yl)-8a-methyl-2,3,4,4a,5,6,7,8-octahydro-1H-naphthalen-2-yl] 3,4-dihydroxy-2-methylidenebutanoate
C21H30O9_Azuleno[4,5-b]furan-2(3H)-one, 8-(beta-D-glucopyranosyloxy)decahydro-6-hydroxy-6-methyl-3,9-bis(methylene)-, (3aS,6R,6aR,8S,9aR,9bS)
Perospirone
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C28197 - Antianxiety Agent Perospirone (SM-9018 free base) is an orally active antagonist of 5-HT2A receptor (Ki=0.6 nM) and dopamine D2 receptor (Ki=1.4 nM), and also a partial agonist of 5-HT1A receptor (Ki=2.9 nM). Perospirone is an atypical antipsychotic agent and has the potential for schizophrenic disease research[1][2].
[5-formyl-4,8-dihydroxy-3-(3-methoxy-3-oxoprop-1-en-2-yl)-8a-methyl-2,3,4,4a,5,6,7,8-octahydro-1H-naphthalen-2-yl] 3,4-dihydroxy-2-methylidenebutanoate
[5-formyl-4,8-dihydroxy-3-(3-methoxy-3-oxoprop-1-en-2-yl)-8a-methyl-2,3,4,4a,5,6,7,8-octahydro-1H-naphthalen-2-yl] 3,4-dihydroxy-2-methylidenebutanoate_major
Ala Ala Glu His
Ala Ala His Glu
Ala Glu Ala His
Ala Glu His Ala
Ala His Ala Glu
Ala His Glu Ala
Asp Gly His Val
Asp Gly Val His
Asp His Gly Val
Asp His Val Gly
Asp Val Gly His
Asp Val His Gly
Glu Ala Ala His
Glu Ala His Ala
Glu His Ala Ala
Phe Phe Gly Gly
Phe Gly Gly Phe
Gly Asp His Val
Gly Asp Val His
Gly Phe Phe Gly
Gly Phe Gly Phe
Gly Gly Phe Phe
Gly His Asp Val
Gly His Val Asp
Gly Val Asp His
Gly Val His Asp
His Ala Ala Glu
His Ala Glu Ala
His Asp Gly Val
His Asp Val Gly
His Glu Ala Ala
His Gly Asp Val
His Gly Val Asp
His Pro Ser Ser
His Ser Pro Ser
His Ser Ser Pro
His Val Asp Gly
His Val Gly Asp
Pro His Ser Ser
Pro Ser His Ser
Pro Ser Ser His
Ser His Pro Ser
Ser His Ser Pro
Ser Pro His Ser
Ser Pro Ser His
Ser Ser His Pro
Ser Ser Pro His
Val Asp Gly His
Val Asp His Gly
Val Gly Asp His
Val Gly His Asp
Val His Asp Gly
Val His Gly Asp
Win 55212-2
A organic heterotricyclic compound that is 5-methyl-3-(morpholin-4-ylmethyl)-2,3-dihydro[1,4]oxazino[2,3,4-hi]indole substituted at position 6 by a 1-naphthylcarbonyl group. D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002491 - Central Nervous System Agents > D000700 - Analgesics D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators
Phe Gly Phe Gly
Narceine imide
11,13-Dihydrotaraxinic acid glucosyl ester
BIS(N,N,NN-TETRAMETHYL-D-TARTRAMIDEGLYCOLATO)DIBORON
3H-Indolium, 1,3,3-trimethyl-2-[2-(1-methyl-2-phenyl-1H-indol-3-yl)ethenyl]-, chloride (1:1)
2-acetamido-3-o-benzyl-4,6-o-benzylidene-2-deoxy-beta-d-glucopyranosyl azide
Ripisartan
C78274 - Agent Affecting Cardiovascular System > C270 - Antihypertensive Agent > C66930 - Angiotensin II Receptor Antagonist
BIS(N,N,NN-TETRAMETHYL-L-TARTRAMIDEGLYCOLATO)DIBORON
Methanesulfonamide, N-(3-(3-((2,3-dihydro-2-hydroxy-1H-inden-2-yl)methyl)-6-ethyl-3-azabicyclo(3.1.0)hex-6-yl)phenyl)-
Methanone, (2,3-dihydro-5-methyl-3-(4-morpholinylmethyl)pyrrolo(1,2,3-de)-1,4-benzoxazin-6-yl)-1-naphthalenyl-, (S)-
D018373 - Peripheral Nervous System Agents > D018689 - Sensory System Agents D002317 - Cardiovascular Agents > D002121 - Calcium Channel Blockers D002491 - Central Nervous System Agents > D000700 - Analgesics D000077264 - Calcium-Regulating Hormones and Agents D049990 - Membrane Transport Modulators
4-[2-(3-Hydroxyphenyl)ethyl]-2-[4-[2-(3-hydroxyphenyl)ethyl]phenoxy]phenol
Iloperidone
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants C78272 - Agent Affecting Nervous System > C29710 - Antipsychotic Agent N - Nervous system > N05 - Psycholeptics > N05A - Antipsychotics Iloperidone (HP 873) is a D2/5-HT2 receptor antagonist. Iloperidone is an atypical antipsychotic for the schizophrenia symptoms[1][2].
8-(2,4-Dihydroxy-6-pentylphenoxy)-6-hydroxy-3-pentylisochromen-1-one
(1S,12R,23R)-12-methyl-23-(2-methylbut-3-en-2-yl)-3,11,14,16-tetrazahexacyclo[12.10.0.02,11.04,9.015,23.017,22]tetracosa-2,4,6,8,17,19,21-heptaene-10,13-dione
5-methyl-3-[3-[4-[2-(2,2,2-trifluoroethoxy)phenyl]piperazin-1-yl]propyl]-1H-pyrimidine-2,4-dione
D018377 - Neurotransmitter Agents > D018663 - Adrenergic Agents > D018674 - Adrenergic Antagonists
N-[1-[(cyclohexylamino)-oxomethyl]cyclohexyl]-N-(thiophen-2-ylmethyl)-2-pyrazinecarboxamide
(S)-2-trans-abscisic acid beta-D-glucopyranosyl ester
An (S)-2-trans-abscisic acid D-glucopyranosyl ester derived from beta-D-glucopyranose.
2-[[4-(2-Ethoxyanilino)-6-(4-ethoxyanilino)-2-pyrimidinyl]methylidene]propanedinitrile
1-[3-(dimethylamino)propyl]-3-(4-fluorophenyl)-1-[(6-methoxy-2-oxo-1H-quinolin-3-yl)methyl]urea
8-methyl-4-oxo-N-[3-(4-propyl-1-piperazinyl)propyl]-5H-thieno[3,2-c]quinoline-2-carboxamide
1-O-[(2E,4E)-5-(1-hydroxy-2,6,6-trimethyl-4-oxocyclohex-2-en-1-yl)-3-methylpenta-2,4-dienoyl]-D-glucopyranose
N-[(2S,3R,4R,5S,6R)-2-[(2R,3S,4R,5S)-5-Acetamido-1,2,4,6-tetrahydroxyhexan-3-yl]oxy-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
2-[(3S,6aS,8R,10aS)-3-hydroxy-1-(1-oxopropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3,5-difluorophenyl)methyl]acetamide
2-[(3R,6aR,8R,10aR)-3-hydroxy-1-(1-oxopropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3,5-difluorophenyl)methyl]acetamide
2-[(3R,6aS,8S,10aS)-3-hydroxy-1-(1-oxopropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3,5-difluorophenyl)methyl]acetamide
2-[(3S,6aR,8R,10aR)-3-hydroxy-1-(1-oxopropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3,5-difluorophenyl)methyl]acetamide
[(2S,3R)-6-(benzenesulfonyl)-1-(cyclopentylmethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-2-yl]methanol
2-[(3R,6aS,8R,10aS)-3-hydroxy-1-(1-oxopropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3,5-difluorophenyl)methyl]acetamide
2-[(3S,6aS,8S,10aS)-3-hydroxy-1-(1-oxopropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3,5-difluorophenyl)methyl]acetamide
2-[(3S,6aR,8S,10aR)-3-hydroxy-1-(1-oxopropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3,5-difluorophenyl)methyl]acetamide
2-[(3R,6aR,8S,10aR)-3-hydroxy-1-(1-oxopropyl)-3,4,6,6a,8,9,10,10a-octahydro-2H-pyrano[2,3-c][1,5]oxazocin-8-yl]-N-[(3,5-difluorophenyl)methyl]acetamide
N,N-dimethyl-4-[4-[(1R,5S)-3-[oxo(2-pyridinyl)methyl]-3,6-diazabicyclo[3.1.1]heptan-7-yl]phenyl]benzamide
[(2S,3S)-6-(benzenesulfonyl)-1-(cyclopentylmethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-2-yl]methanol
[(2R,3R)-6-(benzenesulfonyl)-1-(cyclopentylmethyl)-3-phenyl-1,6-diazaspiro[3.3]heptan-2-yl]methanol
(S)-2-trans-abscisic acid D-glucopyranosyl ester
A carboxylic ester that results from the condensation of the carboxylic acid group of (S)-2-trans-abscisic acid with the anomeric hydroxy group of D-glucopyranose.
N-[(3R,4R,5S,6R)-2-[(2R,3R,4R,5S)-5-Acetamido-2,3,4,6-tetrahydroxyhexoxy]-4,5-dihydroxy-6-(hydroxymethyl)oxan-3-yl]acetamide
1-[2-(cyclohexen-1-yl)ethyl]-5-[(E)-3-(3,4-dimethoxyphenyl)prop-2-enoyl]-1,3-diazinane-2,4,6-trione
3-(4-hydroxyphenyl)-1-[2,4,6-trihydroxy-3-[(2Z)-3-(hydroxymethyl)-7-methylocta-2,6-dienyl]phenyl]propan-1-one
9-Hydroxy-risperidone
D002492 - Central Nervous System Depressants > D014149 - Tranquilizing Agents > D014150 - Antipsychotic Agents D002491 - Central Nervous System Agents > D011619 - Psychotropic Drugs > D014149 - Tranquilizing Agents D018377 - Neurotransmitter Agents > D018490 - Serotonin Agents > D012702 - Serotonin Antagonists D018377 - Neurotransmitter Agents > D015259 - Dopamine Agents > D018492 - Dopamine Antagonists D002491 - Central Nervous System Agents > D002492 - Central Nervous System Depressants
2-trans-abscisic acid D-glucosyl ester
An enoate ester that results from the condensation of the carboxylic acid group of 2-trans-abscisic acid with the anomeric hydroxy group of D-glucopyranose.
Etrumadenant
Etrumadenant (AB928) is an orally bioavailable, selective dual adenosine receptor (A2aR/A2bR) antagonist. Etrumadenant relieves adenosine-mediated immune suppression. Etrumadenant has immunomodulatory and antitumor activities[1][2].
His-[D-2-ME-Trp]-Ala
His-[D-2-ME-Trp]-Ala is a fragment of the growth hormone hexarelin.
3-hydroxy-3-methyl-6,9-dimethylidene-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[4,5-b]furan-2-one
7,8-diformyl-4a-hydroxy-4,4,8a-trimethyl-2,3,5,8-tetrahydro-1h-naphthalen-1-yl 3-(4-methoxyphenyl)prop-2-enoate
3,10-dimethyl-2-oxo-9-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-carbaldehyde
2-(3,3-dimethylbutyl)-1,3,6-trihydroxy-7-methoxy-8-(3-methylbut-2-en-1-yl)xanthen-9-one
(2r,3r)-6-(2-hydroxyethyl)-2-(hydroxymethyl)-2,5,7-trimethyl-3-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h-inden-1-one
(3r,3ar,6ar,8s,9ar,9br)-3-hydroxy-3-methyl-6,9-dimethylidene-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[4,5-b]furan-2-one
4-[2-(2-hydroxyphenyl)ethyl]-2-{4-[2-(3-hydroxyphenyl)ethyl]phenoxy}phenol
2-[(4-methylpentyl)oxy]-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol
(1s,5s,10r)-5-(3,4-dihydroxyphenyl)-9-hydroxy-13,13-dimethyl-2-(3-methylbut-2-en-1-yl)-4,14-dioxatricyclo[8.4.0.0³,⁸]tetradeca-2,8-dien-7-one
5a-methyl-3-methylidene-2-oxo-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydro-3ah-naphtho[1,2-b]furan-9-carbaldehyde
4-[2-(3-hydroxyphenyl)ethyl]-2-{4-[2-(3-hydroxyphenyl)ethyl]phenoxy}phenol
3-methyl-2-oxo-10-{[(3,4,5-trihydroxy-6-methoxyoxan-2-yl)oxy]methyl}-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-carbaldehyde
4-hydroxy-3,6-dimethyl-9-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-3h,3ah,4h,5h,7h,9ah,9bh-azuleno[4,5-b]furan-2-one
(1s,4r,10s,11s,15s)-5,5,10,13,15-pentamethyl-6,19,22-trioxahexacyclo[13.7.1.0¹,¹¹.0⁴,¹⁰.0¹³,²¹.0¹⁷,²¹]tricosa-8,16-diene-7,14,18-trione
(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl (3s,3as,11as)-3,10-dimethyl-2-oxo-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-carboxylate
(1r,4ar,8r,8as)-7,8-diformyl-4a-hydroxy-4,4,8a-trimethyl-2,3,5,8-tetrahydro-1h-naphthalen-1-yl (2e)-3-(4-methoxyphenyl)prop-2-enoate
4-[(1s,3ar,4s,6ar)-4-{3-methoxy-4-[(3-methylbut-2-en-1-yl)oxy]phenyl}-hexahydrofuro[3,4-c]furan-1-yl]-2-methoxyphenol
(3as,5ar,6s,7r,9as,9bs)-7-hydroxy-5a,9-dimethyl-3-methylidene-6-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3ah,4h,5h,6h,7h,9ah,9bh-naphtho[1,2-b]furan-2-one
(2s,3r)-5-hydroxy-2-(2-hydroxypropan-2-yl)-3-[(3s)-3-(2-hydroxypropan-2-yl)-7-methyl-2,3-dihydro-1,4-benzodioxin-5-yl]-2,3-dihydro-1h-indene-4-carbaldehyde
3-(3-hydroxy-1,4-dioxonaphthalen-2-yl)-2,2-dimethylpropyl 5-(2,3-dimethyloxiran-2-yl)-2-methylpent-2-enoate
(3as,6r,6ar,8s,9ar,9bs)-6-hydroxy-6-methyl-3,9-dimethylidene-8-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[4,5-b]furan-2-one
(2r)-2-[(2s,3s)-8-methyl-3-({[(2s,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}carbonyl)-1,2,3,5,6,7-hexahydronaphthalen-2-yl]propanoic acid
(2s)-4-hydroxy-6-(2-hydroxyethyl)-2,5,7-trimethyl-2-({[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)-3h-inden-1-one
6-(hydroxymethyl)-3-methyl-9-methylidene-6-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,3ah,6ah,7h,8h,9ah,9bh-azuleno[4,5-b]furan-2-one
9-hydroxy-9-methyl-3,6-dimethylidene-8-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-octahydroazuleno[4,5-b]furan-2-one
2,18-dimethyl 17,18-dihydroxy-2,12-diazahexacyclo[14.2.2.1⁹,¹².0¹,⁹.0³,⁸.0¹⁶,²¹]henicosa-3,5,7,14-tetraene-2,18-dicarboxylate
3-methyl-5-(2,6,6-trimethyl-4-oxo-1-{[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}cyclohex-2-en-1-yl)penta-2,4-dienoic acid
(1r,3r,4s,9s,16s,18s,19r,21s)-16-(hydroxymethyl)-13-methoxy-12,20-dimethyl-11,14-dioxo-5-oxa-8,17,20-triazahexacyclo[15.3.1.0³,¹⁹.0⁴,⁸.0⁹,¹⁸.0¹⁰,¹⁵]henicosa-10(15),12-diene-21-carbonitrile
methyl 3-{1,6-dimethoxy-2-oxo-10'-oxa-5'-azaspiro[indole-3,2'-tricyclo[5.3.1.0⁴,⁸]undecan]-5'-en-6'-yl}but-2-enoate
3-{[(3r,3as,4s)-3-hydroxy-3-[(1s)-1-hydroxy-2-methylpropyl]-1,4-dimethyl-2-oxo-5,6-dihydro-4h-pentalen-3a-yl]methyl}-4-hydroxy-5-methylchromen-2-one
(3s,3as,9r,11as)-3,10-dimethyl-2-oxo-9-{[(2r,3r,4s,5s,6r)-3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}-3h,3ah,4h,5h,8h,9h,11ah-cyclodeca[b]furan-6-carbaldehyde
11'-hydroxy-2,2,2',9',12'-pentamethyl-6',15'-dimethylidene-13'-oxaspiro[pyran-3,5'-tetracyclo[7.5.1.0¹,¹¹.0²,⁷]pentadecane]-6,10',14'-trione
2-(hexyloxy)-6-({[3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl]oxy}methyl)oxane-3,4,5-triol
10β,14-dihydroxy-10(14),11β(13)-tetrahydro-8,9-didehydro-3-deoxyzaluzanin c10-o-β-d-glucopyranoside
{"Ingredient_id": "HBIN000060","Ingredient_name": "10\u03b2,14-dihydroxy-10(14),11\u03b2(13)-tetrahydro-8,9-didehydro-3-deoxyzaluzanin c10-o-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C21H30O9","Ingredient_Smile": "CC1C2C=CC(C3CCC(=C)C3C2OC1=O)(CO)OC4C(C(C(C(O4)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "6142","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
1(10),4,11(13)-germacratrien-12,6-olid-14-oic acid; (1(10)z,4e,6α)-form,11,13-dihydro,beta-d-glucopyranosyl ester
{"Ingredient_id": "HBIN000218","Ingredient_name": "1(10),4,11(13)-germacratrien-12,6-olid-14-oic acid; (1(10)z,4e,6\u03b1)-form,11,13-dihydro,beta-d-glucopyranosyl ester","Alias": "NA","Ingredient_formula": "C21H30O9","Ingredient_Smile": "NA","Ingredient_weight": "0","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "NA","TCMSP_id": "NA","TCM_ID_id": "9728","PubChem_id": "NA","DrugBank_id": "NA"}
11β,13-dihydrotaraxinic acid
{"Ingredient_id": "HBIN000361","Ingredient_name": "11\u03b2,13-dihydrotaraxinic acid","Alias": "NA","Ingredient_formula": "C21H30O9","Ingredient_Smile": "CC1C2CCC(=CCCC(=CC2OC1=O)C)C(=O)OC3C(C(C(C(O3)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41594","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
11β,13-dihydro-taraxinicacid-1'-o-β-d-glucopyranoside
{"Ingredient_id": "HBIN000362","Ingredient_name": "11\u03b2,13-dihydro-taraxinicacid-1'-o-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C21H30O9","Ingredient_Smile": "CC1C2C(CC(=C)C3CC(C(=C)C3C2OC1=O)O)OC4C(C(C(C(O4)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "5723","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
11β,13-dihydrotaraxinic acid β-glucopyranosyl ester
{"Ingredient_id": "HBIN000363","Ingredient_name": "11\u03b2,13-dihydrotaraxinic acid \u03b2-glucopyranosyl ester","Alias": "NA","Ingredient_formula": "C21H30O9","Ingredient_Smile": "CC1C2CCC(=CCCC(=CC2OC1=O)C)C(=O)OC3C(C(C(C(O3)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "41595","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2r,3r-pterosin l-2'-o-β-d-glucoside
{"Ingredient_id": "HBIN006457","Ingredient_name": "2r,3r-pterosin l-2'-o-\u03b2-d-glucoside","Alias": "NA","Ingredient_formula": "C21H30O9","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "18126","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
2s,3r-pterosin l-2'-o-β-d-glucoside
{"Ingredient_id": "HBIN006686","Ingredient_name": "2s,3r-pterosin l-2'-o-\u03b2-d-glucoside","Alias": "NA","Ingredient_formula": "C21H30O9","Ingredient_Smile": "Not Available","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "18127","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
(3s)-3-hydroxyatractylenolide iii3-o-β-d-glucopyranoside
{"Ingredient_id": "HBIN009613","Ingredient_name": "(3s)-3-hydroxyatractylenolide iii3-o-\u03b2-d-glucopyranoside","Alias": "NA","Ingredient_formula": "C21H30O9","Ingredient_Smile": "CC1=C2CC3C(=C)C(CCC3(CC2(OC1=O)O)C)OC4C(C(C(C(O4)CO)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "9805","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}
9α-hydroxy-11β,13-dihydrozaluzanin c3-o-β-allopyranoside
{"Ingredient_id": "HBIN014042","Ingredient_name": "9\u03b1-hydroxy-11\u03b2,13-dihydrozaluzanin c3-o-\u03b2-allopyranoside","Alias": "NA","Ingredient_formula": "C21H30O9","Ingredient_Smile": "CC1C2CC(C(=C)C3CC(C(=C)C3C2OC1=O)OC4C(C(C(C(O4)CO)O)O)O)O","Ingredient_weight": "NA","OB_score": "NA","CAS_id": "NA","SymMap_id": "NA","TCMID_id": "10011","TCMSP_id": "NA","TCM_ID_id": "NA","PubChem_id": "NA","DrugBank_id": "NA"}